| IONIS PHARMACEUTICALS |
| USA |
| Gesundheit |
| US4622221004 / A2ACMZ |
| ISI (Frankfurt) / IONS (NASDAQ) |
| FRA:ISI, ETR:ISI, ISI:GR, NASDAQ:IONS |
| - |
| https://www.ionispharma.c.. |
|
Ionis Pharmaceuticals, Inc. is a commercial-stage biotechnology company focused on discovering and developing RNA-targeted medicines. Using its proprietary antisense technology, Ionis creates therapies designed to modulate gene expression and address..
>Volltext.. |
| 5989.39 Mio. EUR |
| 6108.03 Mio. EUR |
| 784.33 Mio. EUR |
| -509.84 Mio. EUR |
| -506.97 Mio. EUR |
| -3.12 EUR |
| 1964.97 Mio. EUR |
| 314.24 Mio. EUR |
| -445.62 Mio. EUR |
| 6.51 |
| -4.58% |
| -117.48% |
| - |
| - |
| - |
| IONIS |
| 09.11.26 |